Global Clinical Microbiology Market Size Is Expected To Reach USD 16.7 Billion By 2025

The global clinical microbiology market size is expected to reach USD 16.7 billion by 2025. It is projected to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology depends on technical and skilled workforce to process and interpret results of clinical specimens. Clinical staff have been complaining about poor Turnaround Time (TAT) of tests. However, with technological advancements, a number of laboratory instruments and equipment are being replaced with automated devices to minimize human error and dependency on skilled workforce.

Request A Sample Copy Of This Market Report @:
https://www.radiantinsights.com/research/clinical-microbiology-market/request-sample

In addition, automation has benefits such as reduced TAT and use of labor and lab space, thereby reducing overall cost associated with these tests. Manufacturers are focusing on introduction of automatic specimen processing, plate reading, and organism identification. GE Healthcare, PerkinElmer, and Thermo Fisher are some of the key players offering automated systems in the diagnostics industry.

Rising cases of hospital-acquired infections (HAI) is also fueling demand for clinical microbiology for diagnosis and monitoring. As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. Introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in future.

Browse Full Research of This Market Report With TOC @:
https://www.radiantinsights.com/research/clinical-microbiology-market

Further key findings from the study suggest:
• Owing to rapid adoption of technology and automation of work flow, laboratory instruments are expected to form the fastest growing segment over the forecast period
• Reagents captured the largest revenue share in 2016 owing to repeat purchase of reagents
• In 2015, North America dominated the global market. Continuous research on infectious disease treatment and subsequent grants from government healthcare agencies are contributing to development of a strong ecosystem in the region
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period owing to rising geriatric population in India, China, and Japan. This has resulted in high prevalence of re-emerging infectious diseases such as tuberculosis, cholera, and typhoid
• The clinical microbiology market is presently dominated by a few key participants such as bioMerieux S.A.; Cepheid Inc.; Danaher Corporation; and Bruker Corporation
• Other prominent players operating in the market include Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc.

Contact Details:
Michelle Thoras 
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com